Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v3.19.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Income Statement [Abstract]    
Revenues $ 0 $ 65,000
Cost of revenues 0 13,000
Gross profit 0 52,000
Research and development expense 476 462
Selling, general and administrative expenses 7,945 8,307
Total operating expenses 8,421 8,769
Income (loss) from operations (8,421) 43,231
Other income (expense)    
Change in fair value of warrant liability 0 (2,106)
Interest expense (118) (420)
Interest and other income 204 36
Income (loss) before income taxes (8,335) 40,741
Provision (benefit) for income taxes (2,333) 11,522
Net income (loss) (6,002) 29,219
Accretion of preferred stock 0 (925)
Net income (loss) to common stockholders $ (6,002) $ 28,294
Net income (loss) per share, basic (in dollars per share) $ (0.22) $ 1.05
Net income (loss) per share, diluted (in dollars per share) (0.22) 0.96
Net income (loss) per share applicable to common stockholders, basic (in dollars per share) (0.22) 1.02
Net income (loss) per share applicable to common stockholders, diluted (in dollars share) $ (0.22) $ 0.93
Weighted-average common shares outstanding, basic (in shares) 27,594,372 27,719,689
Weighted-average common shares outstanding, diluted (in shares) 27,594,372 30,284,175